Autism Care Provider Organization, Cortica Raises $80 Million

Morgan Health, a JPMorganChase business unit, and Nexux NeuroTech Ventures co-led an $80 million raise in Cortica, which provides treatment for children diagnosed with autism and other neurodevelopmental conditions. Autism Impact Fund, an existing Cortica investor, also participated in the raise.

The investment will be used to scale Cortica’s ability to offer whole child care to further integrate behavioral and medical care solutions in health benefit design. A key goal is to reduce delays in developmental disability diagnosis and treatment. Through this investment, Morgan Health aims to:

Help Cortica grow the number of whole-child, value-based contracts . . .